London, 05 May 2015 – As the prevalence of infectious diseases increases, the global POC infectious diseases market is expected to grow at a CAGR of 7.50% from 2015-2019, says research firm Technavio.
About the Report
There has been a drastic rise in morbidity and mortality because of infectious diseases. Global climate change, an increase in antibiotic use, aging population and population expansion are some of the reasons for the emergence of infectious diseases.
“In 2011, the Center for Disease Control and Prevention estimated that the number of visits to physicians’ offices because of infectious diseases was nearly 23 million in the US alone,” says Faisal Ghaus, Vice President of Technavio.
According to the latest market research report by Technavio, the market is experiencing a shift from a physician-centered to more patient-centered model, which is positively impacting market growth.
“Patient-centered marketing is an invaluable opportunity that helps captivate both patients and caregivers. This also makes them more likely to bring the same information into their treatment discussions with a physician,” says Ghaus.
Market Scope and Calculation of Market Size
This report covers the current scenario and growth prospects of the global POC infectious diseases market from 2015-2019. To calculate the market size, the report considers revenue generated from testing kits and devices used in major infectious diseases like flu, tuberculosis, malaria, RSV and fecal occult blood etc.
Key Information Covered in the Report:
Key Vendors:
- Alere Inc.
- Meridian Bioscience Inc.
- OraSure Technologies Inc.
- Trinity Biotech plc
Market Growth Drivers:
- Increase in prevalence of infectious diseases
- For a full detailed list, view our report.
Market Challenges:
- Lack of awareness about POC devices
- For a full detailed list, view our report.
Market Trends:
- Shift from physician-centered to patient-centered model
- For a full detailed list, view our report.
https://www.technavio.com/%3Cp%3E%3Ca%20href%3D%22http%3A//www.technavio….
